LncRNA LOC285758 Induced Non-Small Cell Lung Cancer Development through Up-Regulating CDK6 by Sponge Adsorption of miRNA-204
Background: Non-coding RNA played one pivotal role in NSCLC in terms of pathogenesis and progression. We aimed to determine the LncRNA, which can be one new potential target for NSCLC treatment and its possible mechanisms from Jan 2017 to Aug 2020.
Methods: Gene LOC285758, which produced new cells in tumor cellular system, was knocked out. Its specific effects were tested in terms of cellular phenotype. LOC285758 was chosen to target for miRNA as well as downstream mRNA targeted by miRNA, which verified the combination predicted before. Specific impacts brought from miRNA on NSCLC cells were examined. At last, dynamic impacts produced through miRNA and LOC285758 on mRNA expression and NSCLC cellular phenotype were examined.
Results: LOC285758 expression was up-regulated in tissues and cells from NSCLC. Knocking out gene LOC285758 could repress cellular survival and migration of A549 and H292 cells. miRNA-204 was repressed via LOC285758 targeting. miRNA-204 over-expressing repressed invasion ability of NSCLC cells and CDK6 targeted by miRNA-204. CDK6 knocking out suppressed survival and migration of NSCLC cells. The influence brought from gene LOC285758 knocking out could be reversed through suppressing miRNA-204, causing up-regulated CDK6 as well as LOC285758 expression in NSCLC tissues. miRNA-204 was negatively correlated with CDK6 as well as LOC285758, respectively. Nonetheless, CDK6 possessed the positive relationship with LOC285758.
Conclusion: An axis of lncRNA LOC285758/miRNA-204/CDK6 can modulate NSCLC cells in terms of migration as well as survival.
2. Ferlay J, Soerjomataram I, Dikshit R, et al (2015). Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Can-cer, 136: E359-E386.
3. Siegel R, Ward E, Brawley O, Jemal A (2014). Cancer statistics. Ca Cancer J Clin. 67: 7.
4. Ganai S, Ferguson MK (2012). Quality of life in the high risk candidate for lung re-section. Thorac Surg Clin, 22: 497-508.
5. Andersen RE, Lim DA (2018). Forging our understanding of lncRNAs in the brain. Cell Tissue Res. 371: 55-71.
6. Jarroux J, Morillon A, Pinskaya M (2017). History, discovery, and classification of lncRNAs. Adv Exp Med Biol, 1008: 1-46.
7. Li X, Wu Z, Fu X, Han W (2014). LncRNAs: insights into their function and mechanics in underlying disorders. Mutat Res Rev Mutat Res, 762: 1-21.
8. Zhou D, Xie M, He B, Gao Y, Yu Q, He B, Chen Q (2017). Microarray data re-annotation reveals specific lncRNAs and their potential functions in non-small cell lung cancer subtypes. Mol Med Rep, 16: 5129-5136.
9. Wang LL, Zhang M (2018). MiR-582-5p is a potential prognostic marker in human non-small cell lung cancer and functions as a tumor suppressor by targeting MAP3K2. Eur Rev Med Pharmacol Sci, 22: 7760-7767.
10. Liu B, Li J, Cairns MJ (2014). Identifying miRNAs, targets and functions. Brief Bio-inform, 15: 1-19.
11. Kabekkodu SP, Shukla V, Varghese VK, D’ SJ, Chakrabarty S (2018), Satyamoorthy K. Clustered miRNAs and their role in biological functions and diseases. Biol Rev Camb Philos Soc, 93: 1955-1986.
12. Zealy RW, Wrenn SP, Davila S, Min KW, Yoon JH (2017). MicroRNA-binding proteins: specificity and function. Wiley In-terdiscip Rev RNA, 8. doi: 10.1002/wrna.1414. Epub.
13. Wu Q, Yang Z, Shi Y, Fan D (2014). MiR-NAs in human cancers: the diagnostic and therapeutic implications. Curr Pharm Des, 20: 5336-5347.
14. Duan S, Wu A, Chen Z, Yang Y, Liu L, Shu Q (2018). MiR-204 regulates cell prolifera-tion and invasion by targeting EphB2 in human cervical cancer. Oncol Res, 26: 713-723.
15. Liu Z, Long J, Du R, Ge C, Guo K, Xu Y (2016). MiR-204 regulates the EMT by targeting snai1 to suppress the invasion and migration of gastric cancer. Tumour Biol, 37: 8327-8335.
16. Xue F, Che H (2020). The long non-coding RNA LOC285758 promotes invasion of acute myeloid leukemia cells by down-regulating miR-204. FEBS Open Bio, 10(5).
17. Matjasic A, Popovic M, Matos B, Glavac D (2017). Expression of LOC285758, a Po-tential Long Non-coding Biomarker, is Methylation-dependent and Correlates with Glioma Malignancy Grade. Radiol Oncol, 51(3).
18. Pei Y, Li K, Lou X, et al (2020). miR‑1299/NOTCH3/TUG1 feedback loop contributes to the malignant prolif-eration of ovarian cancer. Oncol Rep, 4(2):438-448.
19. Lin YC, Lin JF, Tsai TF, Chou KY, Chen HE, Hwang TI (2017). Tumor suppres-sor miRNA-204-5p promotes apoptosis by targeting BCL2 in prostate cancer cells. Asian J Surg, 40(5): 396-406.
20. Hu L, Kolibaba H, Zhang S, et al (2019). MicroRNA-204-5p Inhibits Ovarian Cancer Cell Proliferation by Down-Regulating USP47. Cell Transplant, 28 (1 Suppl): 51S–58S.
21. Anastasiadou E, Jacob LS, Slack FJ (2018). Non-coding RNA networks in cancer. Nat Rev Cancer, 18: 5-18.
22. Slaby O, Laga R, Sedlacek O (2017). Thera-peutic targeting of non-coding RNAs in cancer. Biochem J, 474: 4219-4251.
23. Wu T, Du Y (2017). LncRNAs: from basic research to medical application. Int J Biol Sci, 13: 295-307.
24. Zhang CG, Yin DD, Sun SY, Han L (2017). The use of lncRNA analysis for stratifica-tion management of prognostic risk in patients with NSCLC. Eur Rev Med Phar-macol Sci, 21: 115-119.
25. Zhao X, Liu Y, Yu S (2017). Long noncod-ing RNA AWPPH promotes hepatocellu-lar carcinoma progression through YBX1 and serves as a prognostic biomarker. Bi-ochim Biophys Acta Mol Basis Dis, 1863: 1805-1816.
|Issue||Vol 51 No 9 (2022)|
|Cancer Micro RNAs Cellular|
|Rights and permissions|
|This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.|